Literature DB >> 7221848

An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis.

M Makiuchi, M Miyakawa, A Sugenoya, R Furihata.   

Abstract

A follow-up survey of 447 patients who had undergone a subtotal thyroidectomy was carried out. In this study, 433 patients were observed, and the follow-up period ranged from one year to ten years. The incidence postoperatively of a recurrence and hypothyroidism was 9.6 and 2.3 per cent, respectively. Transient subclinical hypothyroidism was observed in most patients within three to six months after the operation. This state, however, recovered spontaneously to the euthyroid state within one year. Recurrent hyperthyroidism tends to increase with the lapse of years, while permanent hypothyroidism developed during the first or second year after operation. Results of our investigation suggest that the size of the remnant thyroid appears to play the most important role for an expected long term remission, and the optimal weight of the remnant thyroid should be approximately 10 grams. Although the precise mechanism of remission by surgical ablation of the thyroid has not been clarified, surgical treatment is an effective and safe procedure which controls the condition of the patient with thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7221848

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  6 in total

1.  A comparative evaluation of the surgical and radioiodine treatments for Graves' disease.

Authors:  T Harada; M Katagiri; K Shimaoka; K Ito
Journal:  Jpn J Surg       Date:  1989-01

2.  Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.

Authors:  Pablo Moreno; José M Gómez; Núria Gómez; José M Francos; Emilio Ramos; Antonio Rafecas; E Jaurrieta
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

3.  Thyroidectomy for Graves' disease: is hypothyroidism inevitable?

Authors:  M Davenport; C H Talbot
Journal:  Ann R Coll Surg Engl       Date:  1989-03       Impact factor: 1.891

4.  Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.

Authors:  K Sugino; T Mimura; K Toshima; H Iwabuchi; Y Kitamura; M Kawano; O Ozaki; K Ito
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

5.  The outcome of patients with thyroid carcinoma and Graves' disease.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; H Masuda; F Iida
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

6.  Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; G Kaneko; H Masuda; M Fujimori; S Takahashi; F Iida
Journal:  Jpn J Surg       Date:  1990-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.